[1]
N. Tyagi, N. Kumar, S. Mehan, A. Singh, and S. Kumar, “IN-SILICO EVALUATION OF ROSIGLITAZONE PRODRUG AGAINST NEURODEGENERATIVE DISEASE”, journal, vol. 7, no. 3, pp. 42-47, Oct. 2024.